Toukeibu Gan
Online ISSN : 1881-8382
Print ISSN : 1349-5747
ISSN-L : 1349-5747
INDICATION AND LIMITATION OF SCL-CHEP
Meijin NAKAYAMAKentaro OHASHIYutomo SEINOShunsuke MIYAMOTOMasahiko TAKEDASatoru YOKOBORIMakito OKAMOTO
Author information
JOURNAL FREE ACCESS

2006 Volume 32 Issue 3 Pages 311-314

Details
Abstract

Supracricoid laryngectomy with cricohyoidoepiglotto-pexy (SCL-CHEP) is an organ preservation surgery for treating glottic carcinoma. Respiration from the natural airway, restoration of laryngeal functions, and superior oncological results can be achieved post-operatively. SCL-CHEP is mainly indicated for massive T2 and T3 glottic carcinomas. This surgery has become one of the major treatment options in our laryngeal cancer management. Proper selection of the patients, using the advanced technique, and employing appropriate post-operative cares are prerequisites for the success of this treatment.
Further evaluations need to be done to identify whether SCL-CHEP can be one of the standard treatments for laryngeal cancer management in Japan.
Approximately 200 to 300 cases are presumed to be potential candidates for this organ preservation surgery. When the patient desires organ preservation treatment and the surgeon is not experienced with this surgery, one should refer the patient to the appropriate institutes for a second opinion.

Content from these authors
© 2006 Japan Society for Head and Neck Cancer
Previous article Next article
feedback
Top